Definium Therapeutics (DFTX) Stock Forecast, Price Target & Predictions
DFTX Stock Forecast
Definium Therapeutics (DFTX) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $67.45, with a high of $79.00 and a low of $52.00. This represents a 128.80% increase from the last price of $29.48.
DFTX Stock Rating
Definium Therapeutics stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
DFTX Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | Definium Therapeutics | 128.80% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Biotech Stocks | 41.48% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 4 | 27 |
| Avg Price Target | - | $75.50 | $56.00 |
| Last Closing Price | $29.48 | $29.48 | $29.48 |
| Upside/Downside | - | 156.11% | 89.96% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Nov, 26 | 5 | 14 | - | - | - | 19 |
| Oct, 26 | 4 | 14 | - | - | - | 18 |
| Sep, 26 | 4 | 14 | - | - | - | 18 |
| Aug, 26 | 4 | 12 | - | - | - | 16 |
| Jul, 26 | 4 | 11 | - | - | - | 15 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Canaccord Genuity | $78.00 | $40.25 | 93.79% | 164.59% | |
| Sep 15, 2026 | UBS | $70.00 | $40.25 | 73.91% | 137.45% | |
| Sep 15, 2026 | Robert W. Baird | $79.00 | $40.25 | 96.27% | 167.98% | |
| Sep 14, 2026 | Oppenheimer | $75.00 | $40.25 | 86.34% | 154.41% | |
| Aug 14, 2026 | Maxim Group | $55.00 | $42.88 | 28.26% | 86.57% | |
| Aug 13, 2026 | Sumant Kulkarni | Canaccord Genuity | $64.00 | $42.79 | 49.57% | 117.10% |
| Aug 13, 2026 | Robert W. Baird | $75.00 | $42.79 | 75.27% | 154.41% | |
| Aug 12, 2026 | RBC Capital | $66.00 | $42.79 | 54.24% | 123.88% | |
| Aug 12, 2026 | Needham | $66.00 | $42.79 | 54.24% | 123.88% | |
| Aug 12, 2026 | Oppenheimer | $70.00 | $43.05 | 62.60% | 137.45% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 19, 2026 | RBC Capital | Outperform | Outperform | hold |
| Sep 15, 2026 | H.C. Wainwright | Buy | Buy | hold |
| Sep 14, 2026 | Oppenheimer | Outperform | Outperform | hold |
| Aug 12, 2026 | RBC Capital | Outperform | Outperform | hold |
| Aug 12, 2026 | Needham | Buy | Buy | hold |
| Aug 12, 2026 | Oppenheimer | Outperform | Outperform | hold |
| Jul 27, 2026 | Wells Fargo | Overweight | initialise | |
| Jul 24, 2026 | Piper Sandler | Overweight | Overweight | hold |
| Jun 25, 2026 | UBS | Positive | Positive | hold |
| Jun 23, 2026 | Needham | Buy | Buy | hold |
Financial Forecast
EPS Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | Dec 29 | |
|---|---|---|---|---|---|---|
| Reported | $-1.54 | $-2.06 | - | - | - | - |
| Avg Forecast | $-1.43 | $-2.01 | $-1.81 | $-1.75 | $-0.58 | $0.95 |
| High Forecast | $-1.43 | $-1.81 | $-1.05 | $-0.50 | $3.60 | $0.95 |
| Low Forecast | $-1.43 | $-2.14 | $-2.20 | $-2.37 | $-2.31 | $0.95 |
| Surprise % | 7.69% | 2.49% | - | - | - | - |
Revenue Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | Dec 29 | |
|---|---|---|---|---|---|---|
| Reported | - | - | - | - | - | - |
| Avg Forecast | - | - | - | $39.36M | $213.34M | $515.74M |
| High Forecast | - | - | - | $39.36M | $221.96M | $515.74M |
| Low Forecast | - | - | - | $39.36M | $204.71M | $515.74M |
| Surprise % | - | - | - | - | - | - |
Net Income Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | Dec 29 | |
|---|---|---|---|---|---|---|
| Reported | $-108.68M | $-183.79M | - | - | - | - |
| Avg Forecast | $-1.01B | $-1.39B | $-1.15B | $-1.01B | $-43.50M | $671.73M |
| High Forecast | $-1.01B | $-1.27B | $-738.99M | $-354.75M | $2.54B | $671.73M |
| Low Forecast | $-1.01B | $-1.51B | $-1.55B | $-1.67B | $-1.63B | $671.73M |
| Surprise % | -89.23% | -86.79% | - | - | - | - |